Millions of people use Ozempic and Wegovy to manage diabetes or lose weight, but a growing number are dealing with an unexpected complication: stomach paralysis, also known as gastroparesis. The same mechanism that helps these drugs curb appetite, slowing digestion, appears in some patients to shut the stomach down almost entirely. Reports of severe nausea, vomiting, and hospitalization have led thousands of patients who were trying to treat their obesity to question whether they were warned about GLP-1 gastroparesis before starting treatment.
This article explains what gastroparesis is, why patients are pursuing lawsuits against the manufacturers of Ozempic and Wegovy, and what steps to take if you developed symptoms after starting a GLP-1 medication. Our firm represents patients nationwide in this litigation, and understanding how the medical science and legal process fit together can help you decide what to do next.
You can reach out to us by filling this form or calling us at (816) 701-1100
Understanding GLP-1 Gastroparesis and Its Serious Side Effects
Ozempic and Wegovy both contain semaglutide, a GLP-1 receptor agonist that mimics a natural gut hormone involved in blood sugar control and appetite regulation. Novo Nordisk markets Ozempic for type 2 diabetes and Wegovy for chronic weight management, though both drugs work through the same underlying mechanism. Related medications, including Mounjaro and Zepbound, use a similar approach and have drawn comparable safety concerns.
How These Medications Cause Stomach and Gallbladder Problems
GLP-1 drugs are designed to slow gastric emptying, which helps patients feel full longer and keeps blood sugar from spiking after meals. Ozempic’s prescribing information confirms that OZEMPIC delays gastric emptying and states plainly that the drug is not recommended in patients with severe gastroparesis. In most patients, this slowing is mild and temporary, but in others it appears to progress into a diagnosable, sometimes lasting form of stomach paralysis.
Most Common Side Effects of Ozempic and Wegovy
The most commonly reported Wegovy side effects and Ozempic side effects include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation. Postmarketing reports have also documented more serious gastrointestinal reactions, including ileus, intestinal obstruction, and severe constipation, including fecal impaction. When symptoms persist beyond the typical dose-adjustment period, or return after the medication has been stopped, they may signal something more serious than routine digestive system upset.
The Ozempic and Wegovy Gastroparesis Lawsuits
Patients pursuing claims allege that Novo Nordisk and other manufacturers knew or should have known about the risk of severe, lasting gastroparesis well before their warnings reflected that risk. Federal gastroparesis claims against GLP-1 manufacturers have been centralized into MDL 3094, where thousands of plaintiffs describe similar injuries after starting treatment. Many describe needing emergency care, feeding tubes, or ongoing treatment for symptoms that began during or shortly after GLP-1 use.
How the Federal MDL Litigation Works
The actions in this Multidistrict Litigation are generally personal injury actions stemming from use of glucagon-like peptide-1 receptor agonists, which are medicines prescribed for, among other things, the treatment of type 2 diabetes. These cases are coordinated before a single judge in the Eastern District of Pennsylvania so that shared discovery and expert disputes are handled once rather than separately in every plaintiff’s home court. Consolidation speeds up the early stages of a case, but each plaintiff’s injuries and damages are still evaluated individually.
What the Warning Label Changes Reveal
Manufacturers have gradually revised their labeling over time, and those revisions have become central to the litigation. The current Ozempic label states that OZEMPIC is not recommended in patients with severe gastroparesis, a warning that came years after the drug’s initial approval and widespread use. Plaintiffs argue that these updates arrived only after extensive use and a substantial volume of adverse event reports, not before patients began treatment.
What to do if You Developed Gastroparesis After Taking Ozempic or Wegovy
Gastroparesis is generally confirmed through objective testing, such as a gastric emptying study that measures how quickly food moves through the stomach. Getting this testing done, ideally while you are still experiencing symptoms, creates the kind of medical record that both doctors and courts rely on. Without this documentation, it can be difficult to distinguish ordinary GLP-1 nausea from a more serious, lasting condition.
Document Your Symptoms and Medical History
Keep records of when you started the medication, when symptoms began, and any emergency room visits, hospitalizations, or specialist referrals that followed. Pharmacy records showing fill dates and dosages can help establish the timeline between your GLP-1 use and diagnosis. This kind of documentation strengthens both your ongoing medical care and any legal claim you may decide to pursue.
Understand Your Legal Options and Deadlines
Every state sets its own filing deadline for product liability claims, and that deadline generally starts running once you knew or reasonably should have known your injury was connected to the medication. Missing that window can permanently bar a claim, even when the underlying injury is severe. Speaking with an attorney early gives you time to gather records and evaluate whether your GLP-1 gastroparesis lawsuit qualifies for the ongoing litigation.
Frequently Asked Questions About GLP-1 Gastroparesis Claims
Here are answers to some of the questions patients most often ask our firm about Ozempic, Wegovy, and gastroparesis claims.
Yes. Whether you took Ozempic for diabetes or Wegovy for weight management, both drugs use the same active ingredient and carry the same alleged risk of gastroparesis. The reason your doctor prescribed the medication does not appear to bar a claim under the current litigation.
Deadlines vary by state and are generally tied to when you discovered, or reasonably should have discovered, the connection between your symptoms and the medication. Some states allow only one year, while others allow several years from diagnosis. Because these deadlines are strict, it is best to speak with an attorney as soon as possible after a gastroparesis diagnosis.
No. Some patients continue prescribed treatment even after developing digestive symptoms, especially while weighing the drug’s benefits for diabetes control against new side effects. What matters most for a claim is medical documentation connecting your gastroparesis diagnosis to your GLP-1 use, not whether you are still taking the drug.
Without formal testing, it can be harder to confirm a gastroparesis diagnosis for litigation purposes, though other records may still support a claim. Emergency room visits, hospitalizations, and detailed physician notes describing your symptoms can help fill that gap. An attorney can review your existing records and advise whether additional testing would strengthen your case.
Filing a lawsuit does not affect your ability to receive medical care or access other treatments for diabetes or weight management. Your relationship with your healthcare provider stays separate from any legal claim against the drug manufacturer. Most patients continue working with their doctors throughout the litigation process.
Our firm reviews GLP-1 gastroparesis cases on a contingency basis, meaning there is no upfront cost to have your case evaluated. Attorney fees are only collected if a settlement or verdict results in compensation. This arrangement allows patients to pursue a claim without added financial risk during an already difficult time.
Speak with Our Firm About Your GLP-1 Gastroparesis Claim
If you or a family member developed gastroparesis, ileus, or another serious digestive complication after taking Ozempic, Wegovy, or a similar GLP-1 medication, our firm is available to review your medical history and explain your legal options.
We handle these cases on a contingency basis, so there is no upfront cost to find out where you stand. Reach out to Wagstaff & Cartmell today for a free, confidential consultation about your potential claim.